3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Malnutrition
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Thrombosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Protein Metabolism
1
Polycystic Ovary Syndrome
1
Pain
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Meningioma
1
Hemorrhage
1
Glioblastoma
1
Erectile Dysfunction
1
Disease
1
Diabetes Insipidus
1
Brain Neoplasms
1
Interventions
apixaban
5
Enoxaparin
4
Dalteparin
4
Warfarin
2
Rivaroxaban
2
Injections
2
Heparin, Low-Molecular-Weight
2
Aspirin
2
salicylhydroxamic acid
1
palbociclib
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
X-Rays
1
Tinzaparin
1
Technetium Tc 99m Sulfur Colloid
1
Simvastatin
1
Saline Solution
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Musculoskeletal Manipulations
1
Hydroxyurea
1
Heparin
1
Fondaparinux
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thrombosis
×
Arginine
×
Clear all
NCT05293041
2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4
Completed
248 enrolled